Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019 Apr;7(8):167.
doi: 10.21037/atm.2019.03.26.

Does alfacalcidol reduce cardiovascular complications in hemodialysis patients?

Louis-Charles Desbiens  1   2 , Fabrice Mac-Way  1   2
Affiliations
Editorial

Does alfacalcidol reduce cardiovascular complications in hemodialysis patients?

Louis-Charles Desbiens et al. Ann Transl Med. 2019 Apr.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Comment on

  • Effect of Oral Alfacalcidol on Clinical Outcomes in Patients Without Secondary Hyperparathyroidism Receiving Maintenance Hemodialysis: The J-DAVID Randomized Clinical Trial.
    J-DAVID Investigators; Shoji T, Inaba M, Fukagawa M, Ando R, Emoto M, Fujii H, Fujimori A, Fukui M, Hase H, Hashimoto T, Hirakata H, Honda H, Hosoya T, Ikari Y, Inaguma D, Inoue T, Isaka Y, Iseki K, Ishimura E, Itami N, Ito C, Kakuta T, Kawai T, Kawanishi H, Kobayashi S, Kumagai J, Maekawa K, Masakane I, Minakuchi J, Mitsuiki K, Mizuguchi T, Morimoto S, Murohara T, Nakatani T, Negi S, Nishi S, Nishikawa M, Ogawa T, Ohta K, Ohtake T, Okamura M, Okuno S, Shigematsu T, Sugimoto T, Suzuki M, Tahara H, Takemoto Y, Tanaka K, Tominaga Y, Tsubakihara Y, Tsujimoto Y, Tsuruya K, Ueda S, Watanabe Y, Yamagata K, Yamakawa T, Yano S, Yokoyama K, Yorioka N, Yoshiyama M, Nishizawa Y. J-DAVID Investigators, et al. JAMA. 2018 Dec 11;320(22):2325-2334. doi: 10.1001/jama.2018.17749. JAMA. 2018. PMID: 30535217 Free PMC article. Clinical Trial.

References

    1. U.S Renal Data System. USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases 2010.
    1. KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl (2011) 2017;7:1-59. - PMC - PubMed
    1. Bosworth C, de Boer IH. Impaired vitamin D metabolism in CKD. Semin Nephrol 2013;33:158-68. 10.1016/j.semnephrol.2012.12.016 - DOI - PMC - PubMed
    1. Parikh C, Gutgarts V, Eisenberg E, et al. Vitamin D and Clinical Outcomes in Dialysis. Semin Dial 2015;28:604-9. 10.1111/sdi.12446 - DOI - PMC - PubMed
    1. Palmer SC, McGregor DO, Macaskill P, et al. Meta-analysis: vitamin D compounds in chronic kidney disease. Ann Intern Med 2007;147:840-53. 10.7326/0003-4819-147-12-200712180-00004 - DOI - PubMed